Literature DB >> 8609388

The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.

S Gibson1, A August, Y Kawakami, T Kawakami, B Dupont, G B Mills.   

Abstract

Functional T lymphocyte activation requires concurrent stimulation of the TCR complex and an accessory molecule, most frequently CD28. We have previously demonstrated that the TEC family tyrosine kinase EMT/ITK/TSK (EMT) is activated following cross-linking of CD28. We demonstrate herein that cross-linking of the CD3 component of the TCR complex also leads to EMT activation as indicated by a rapid and transient increase in EMT tyrosine phosphorylation and kinase activity in anti-EMT immunoprecipitates. However, although concurrent cross-linking of the TCR and CD28 results in a marked increase in production of the T cell growth factor IL-2, it does not result in a significant alteration in the magnitude or duration of EMT activation. Somatic cell mutants of the Jurkat T cell line, which lack the SRC family kinase LCK (JCaM1.6), fail to produce IL-2 when stimulated through the TCR complex. EMT activation, as evidenced by increased EMT tyrosine phosphorylation and EMT-associated kinase activity, was also greatly reduced following stimulation of the TCR in the JCaM1.6 Jurkat T cell mutants that lack LCK. In support of a role for LCK in EMT activation, reconstitution of the LCK-negative Jurkat T cell line by enforced expression of LCK restored TCR-mediated EMT activation. Taken together, the data indicate that the EMT tyrosine kinase is activated following cross-linking of the TCR, a process in which LCK likely plays an important role.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609388

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.

Authors:  B J Irvin; B L Williams; A E Nilson; H O Maynor; R T Abraham
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase.

Authors:  Y Kawakami; S E Hartman; E Kinoshita; H Suzuki; J Kitaura; L Yao; N Inagaki; A Franco; D Hata; M Maeda-Yamamoto; H Fukamachi; H Nagai; T Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

3.  rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases.

Authors:  J Debnath; M Chamorro; M J Czar; E M Schaeffer; M J Lenardo; H E Varmus; P L Schwartzberg
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  Genetic evidence of a role for Lck in T-cell receptor function independent or downstream of ZAP-70/Syk protein tyrosine kinases.

Authors:  J Wong; D Straus; A C Chan
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

5.  Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation.

Authors:  Y T Tsai; Y H Su; S S Fang; T N Huang; Y Qiu; Y S Jou; H M Shih; H J Kung; R H Chen
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  A novel function for the Tec family tyrosine kinase Itk in activation of beta 1 integrins by the T-cell receptor.

Authors:  M L Woods; W J Kivens; M A Adelsman; Y Qiu; A August; Y Shimizu
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

7.  Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.

Authors:  S Gibson; K Truitt; Y Lu; R Lapushin; H Khan; J B Imboden; G B Mills
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

8.  Functional analysis of the T-cell-restricted protein tyrosine kinase Txk.

Authors:  J H Ellis; R P Sutmuller; M J Sims; S Cooksley
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

Review 9.  ITK inhibitors in inflammation and immune-mediated disorders.

Authors:  Nisebita Sahu; Avery August
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

10.  SLP-76 mediates and maintains activation of the Tec family kinase ITK via the T cell antigen receptor-induced association between SLP-76 and ITK.

Authors:  Yaron Bogin; Carmit Ainey; Dvora Beach; Deborah Yablonski
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.